Table 3.
Survival analysis of prognostic factors in relapsed patients with B‐NHL
Factor | Survival analysis of relapsed patients | |
---|---|---|
Number | log‐rank p value | |
Age (y) | ||
≤46 | 8 | NA |
>46 | 8 | |
Gender | ||
Male | 28 | NA |
Female | 4 | |
B syndrome | ||
No | 11 | NA |
Yes | 21 | |
LDH levels | ||
≤151 | 9 | 0.037 |
>151 | 23 | |
IPI score | ||
0‐3 | 26 | 0.150 |
>3 | 5 | |
Ann Arbor stage | ||
I‐III | 6 | 0.105 |
IV | 22 | |
M‐MDSC% | ||
≤7.19% | 22 | 0.031 |
>7.19% | 10 | |
G‐MDSC% | ||
≤94.33% | 10 | 0.024 |
>94.33% | 22 |
Note: MDSC level (high/low) is based on the maximally selected rank statistics. Bold values are statistically significant.
Abbreviations: B‐NHL, B‐cell non‐Hodgkin lymphoma; G‐MDSC, granulocyte myeloid‐derived suppressor cells; IPI, International Prognostic Index; LDH, lactic dehydrogenase; M‐MDSC: monocyte MDSC; ND, newly diagnosed.